An Appraisal of Narcolepsy Guidelines

Slides:



Advertisements
Similar presentations
By Minh Tran Narcolepsy. What is Narcolepsy? Narcolepsy is a neurologic disorder characterized by excessive daytime sleepiness and abnormal REM sleep.
Advertisements

BR: Read and annotate sleep disorder reading. SLEEP DISORDERS Night terror Sleep walking Narcolepsy/catap lexy Sleep Apnea.
Narcolepsy Kelly Lewis Jimmy Wells Stacey Leonard.
Neurological Disorder NARCOLEPSY. What is it? Chronic neurological disorder affecting brain’s ability to regulate sleep-wake cycles. Two types: Narcolepsy.
By Minh Tran Narcolepsy. What is Narcolepsy? Narcolepsy is a neurologic disorder characterized by excessive daytime sleepiness and abnormal REM sleep.
EDU 675 Week 4 DQ 1 Adjustable Assignments, Compacting, and Grouping Check this A+ tutorial guideline at ASH/EDU-675-Week-4-DQ-1-Adjustable-
Multimodal Management of Opioid-Induced Constipation
D2L Refresher Upload content into the Content section in a D2L course
Upfront Combination Therapy vs Step-Up Approach for PAH:
IBS-D -- From Diagnosis to Management
Assessing COPD in Primary Care
Primary Care Challenges in Depression - To Treat or Refer?
ICD-10 and Clinical Documentation
Improving the Diagnosis and Treatment of Seizures in Long-term Care
Risk Stratification in PAH: What Do the Latest Data Suggest?
What Is Major Depressive Disorder (MDD)?
The Clinical Enigma of Cardiogenic Shock
Exploring the Spectrum of Excessive Daytime Sleepiness
Fundamental Concepts in the Diagnosis of Advanced NSCLC
Diagnosing Rheumatoid Arthritis Early
Challenges in the Diagnosis of MS: Physician and Nurse Perspectives
The Patient Journey to Remission in MDD: A Collaborative Approach
Diagnostic Algorithms for ACS and High-Sensitivity Troponin
New Challenges Facing Multiple Sclerosis Nurses
Ask the Onychomycosis Expert, Part 2
Optimizing Quality of Life and Mental Health in Patients With Psoriasis.
The Latest Data on Oral Prostacyclin Therapy in PAH
The Role of Imaging in Diagnosing IPF Hands-On Case Studies
Before and After: Patient Cases in Onychomycosis
Diagnosis and Management of Narcolepsy in Psychiatry:
The Mood Disorder Spectrum
What Would You Do in This Case of MDD?
A Call to Action on Cryptogenic Stroke
Screening and Diagnosing Postpartum Depression
Counseling Patients About Germline BRCA Mutations
Liquid Biopsy for RAS Screening in CRC: How Can We Successfully Implement This New Paradigm?
Treating Vasodilatory Shock in the ICU
Improving Narcolepsy Diagnosis
Are We Closer to Personalized Medicine in MS?
Approaches to the Patient With a Runny Nose
Program Goals. The National Quality Strategy and You: How CMS Quality Measures Affect Policy and Practice.
Program Goals Disclaimer Overview Assessing Disease Activity.
Examining the Latest Evidence in PAH
Pseudobulbar Affect or Psychiatric Condition?
Updated Guideline Recommendations for the Definitive Diagnosis of Unexplained Syncope.
What Is Bipolar Disorder?
What's New on Interventions for Lower Limb Spasticity?
Hyperammonemia: Best Practices for Diagnosis and Treatment
Taking the "Cryptogenic" Out of Cryptogenic Stroke
Traditional Stimulants vs Other Wake-Promoting Agents
Introduction to AD. Practical Approaches to the Identification of Alzheimer Disease in Primary Care.
US and European Perspectives on Sinusoidal Obstruction Syndrome
Managing HF in Primary Care
Imaging to Assess IPF Progression A Case-Based Approach
Volume 85, Pages (August 2018) Clinical Characteristics and Burden of Illness in Pediatric Patients with Narcolepsy  Giuseppe Plazzi, MD, PhD, Heather.
Communicating With Your Patients About Major Depressive Disorder
Current Controversies and Advances in Hepatorenal Syndrome
Program Goals Background: Anticoagulation in Patients With VTE.
Treating Atypical Hemolytic Uremic Syndrome A Case Discussion
Taking the "Cryptogenic" Out of Cryptogenic Stroke
Selecting Treatment Approaches in Hemophilia
Diagnosing Myalgic Encephalomyelitis/ Chronic Fatigue Syndrome
So Many Guidelines, So Little Time:
What Is Acute Intermittent Porphyria? Why AIP Is Often Undiagnosed or Misdiagnosed.
Rational Pharmacotherapy Selection for Insomnia
PCSK9 Inhibitors and Statin Intolerance
Binge Eating Disorder.
Managing HF in Primary Care
Shared Decision Making in MS
Presentation transcript:

An Appraisal of Narcolepsy Guidelines

Program Goals

Recognizing Excessive Sleepiness

Background of Narcolepsy

ICSD Narcolepsy Nomenclature

Why Change the Terminology?

Summary of Changes – ICSD-2 vs ICSD-3 Narcolepsy

DSM-5 Narcolepsy

Differences Between DSM-5 and ICSD-3 Narcolepsy

Differences Between DSM-5 and ICSD-3 Narcolepsy (cont)

Differences Between DSM-5 and ICSD-3 Narcolepsy (cont)

Differences Between DSM-5 and ICSD-3 Narcolepsy (cont)

Implementation of Criteria

Implementation of Criteria Defining Cataplexy

Implementation of Criteria Hypocretin Levels

Differential Diagnosis

Case Study – PCP History

Case Study – Sleep Center Assessment

Case Study – Sleep Center Assessment (cont)

Case Study – Sleep Study Results

Case Study – Sleep Study Results (cont)

Case Study – Differential Diagnosis

Summary

Summary (cont)

Abbreviations